1085458-63-4

Basic information

• Product Name: 10-Benzyl-8-oxa-3,10-diaza-bicyclo[4.3.1]decane
• Synonyms: 10-Benzyl-8-oxa-3,10-diaza-bicyclo[4.3.1]decane
• CAS NO: 1085458-63-4
• Molecular Formula: C₁₄H₂₀N₂O
• Molecular Weight: 232
• Mol File: 1085458-63-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 10-Benzyl-8-oxa-3,10-diaza-bicyclo[4.3.1]decane(CAS DataBase Reference)
• NIST Chemistry Reference: 10-Benzyl-8-oxa-3,10-diaza-bicyclo[4.3.1]decane(1085458-63-4)
• EPA Substance Registry System: 10-Benzyl-8-oxa-3,10-diaza-bicyclo[4.3.1]decane(1085458-63-4)

Safety Data

• Hazardous Substances Data: 1085458-63-4(Hazardous Substances Data)

Usage

Chemical structure

A synthetic cannabinoid with a complex chemical structure.

Receptor selectivity

Acts as a potent and selective agonist of the cannabinoid receptors CB1 and CB2.

Therapeutic applications

Studied for potential use in treating pain, inflammation, and neurodegenerative diseases.

Anti-cancer potential

Investigated for its potential as an anti-cancer agent, with some studies showing promising results.

Psychoactive effects

Can cause hallucinations, paranoia, and anxiety in high doses.

Pharmacological profile

Has a complex pharmacological profile that requires further research to fully understand its potential benefits and risks.

Synonyms

Also known as WIN 55,212-2.

Research focus

Widely studied for its potential therapeutic applications and anti-cancer properties.

Dosage considerations

Careful consideration of dosage is necessary due to its psychoactive effects at high doses.

Ongoing research

Further research is needed to fully understand the potential benefits and risks of this compound.

Upstream product

• 1085458-61-2 tert-butyl 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate 
• 1085458-59-8 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decan-4-one 
• 81514-40-1 N-benzyl-7-oxa-9-azabicyclo<3.3.1>nonan-3-one 

Downstream Products

• 1085458-61-2 tert-butyl 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate 
• 1085458-68-9 tert-butyl 10-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate 
• 1085458-32-7 3-(6-fluoroquinazolin-2-yl)-10-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-73-6 (1R,6S)-10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-75-8 (1S,6R)-10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-70-3 C₁₆H₁₉N₅O₂ 

Relevant articles and documents

SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF

The present application relates to novel imidazopyridinyl-or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring.